S&P 500   3,958.13 (-1.02%)
DOW   33,722.13 (-0.66%)
QQQ   283.09 (-1.58%)
AAPL   144.80 (-1.25%)
MSFT   246.73 (-1.39%)
META   116.16 (-5.12%)
GOOGL   97.30 (-2.19%)
AMZN   89.52 (-1.64%)
TSLA   179.20 (-1.78%)
NVDA   161.02 (-3.06%)
NIO   13.14 (+2.66%)
BABA   91.98 (+1.61%)
AMD   71.03 (-3.52%)
T   19.08 (+1.76%)
MU   54.24 (+0.37%)
CGC   3.80 (-12.04%)
F   13.25 (-0.97%)
GE   85.02 (+0.43%)
DIS   93.99 (-2.02%)
AMC   7.04 (-5.50%)
PYPL   72.62 (-1.36%)
PFE   49.91 (-1.62%)
NFLX   306.94 (-1.81%)
S&P 500   3,958.13 (-1.02%)
DOW   33,722.13 (-0.66%)
QQQ   283.09 (-1.58%)
AAPL   144.80 (-1.25%)
MSFT   246.73 (-1.39%)
META   116.16 (-5.12%)
GOOGL   97.30 (-2.19%)
AMZN   89.52 (-1.64%)
TSLA   179.20 (-1.78%)
NVDA   161.02 (-3.06%)
NIO   13.14 (+2.66%)
BABA   91.98 (+1.61%)
AMD   71.03 (-3.52%)
T   19.08 (+1.76%)
MU   54.24 (+0.37%)
CGC   3.80 (-12.04%)
F   13.25 (-0.97%)
GE   85.02 (+0.43%)
DIS   93.99 (-2.02%)
AMC   7.04 (-5.50%)
PYPL   72.62 (-1.36%)
PFE   49.91 (-1.62%)
NFLX   306.94 (-1.81%)
S&P 500   3,958.13 (-1.02%)
DOW   33,722.13 (-0.66%)
QQQ   283.09 (-1.58%)
AAPL   144.80 (-1.25%)
MSFT   246.73 (-1.39%)
META   116.16 (-5.12%)
GOOGL   97.30 (-2.19%)
AMZN   89.52 (-1.64%)
TSLA   179.20 (-1.78%)
NVDA   161.02 (-3.06%)
NIO   13.14 (+2.66%)
BABA   91.98 (+1.61%)
AMD   71.03 (-3.52%)
T   19.08 (+1.76%)
MU   54.24 (+0.37%)
CGC   3.80 (-12.04%)
F   13.25 (-0.97%)
GE   85.02 (+0.43%)
DIS   93.99 (-2.02%)
AMC   7.04 (-5.50%)
PYPL   72.62 (-1.36%)
PFE   49.91 (-1.62%)
NFLX   306.94 (-1.81%)
S&P 500   3,958.13 (-1.02%)
DOW   33,722.13 (-0.66%)
QQQ   283.09 (-1.58%)
AAPL   144.80 (-1.25%)
MSFT   246.73 (-1.39%)
META   116.16 (-5.12%)
GOOGL   97.30 (-2.19%)
AMZN   89.52 (-1.64%)
TSLA   179.20 (-1.78%)
NVDA   161.02 (-3.06%)
NIO   13.14 (+2.66%)
BABA   91.98 (+1.61%)
AMD   71.03 (-3.52%)
T   19.08 (+1.76%)
MU   54.24 (+0.37%)
CGC   3.80 (-12.04%)
F   13.25 (-0.97%)
GE   85.02 (+0.43%)
DIS   93.99 (-2.02%)
AMC   7.04 (-5.50%)
PYPL   72.62 (-1.36%)
PFE   49.91 (-1.62%)
NFLX   306.94 (-1.81%)
NASDAQ:CCCC

C4 Therapeutics - CCCC SEC Filings & 10K Form

$8.16
-0.12 (-1.45%)
(As of 12/6/2022 11:34 AM ET)
Add
Compare
Today's Range
$8.05
$8.32
50-Day Range
$7.58
$10.24
52-Week Range
$4.84
$38.05
Volume
4,016 shs
Average Volume
480,661 shs
Market Capitalization
$399.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.11

Recent C4 Therapeutics SEC Filings

DateFilerForm TypeView
11/03/2022
6:50 AM
C4 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2022
6:21 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2022
5:06 PM
C4 Therapeutics (Issuer)
GROGAN DONNA ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
5:06 PM
C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
5:05 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2022
6:41 AM
C4 Therapeutics (Filer)
Form 8-K/A
08/04/2022
7:31 AM
C4 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2022
7:15 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2022
3:24 PM
C4 Therapeutics (Issuer)
GROGAN DONNA ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2022
3:23 PM
Bessen Laura (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2022
3:20 PM
C4 Therapeutics (Issuer)
GROGAN DONNA ROY (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/02/2022
3:18 PM
Bessen Laura (Reporting)
C4 Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/02/2022
7:33 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2022
4:18 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2022
3:12 PM
C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2022
3:11 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2022
3:16 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2022
3:16 PM
C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2022
3:15 PM
C4 Therapeutics (Issuer)
COHEN MARC A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2022
3:15 PM
C4 Therapeutics (Issuer)
Salter Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2022
3:15 PM
C4 Therapeutics (Issuer)
DOWNEY BRUCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2022
3:45 PM
C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
Form 4/A
06/14/2022
3:45 PM
C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
Form 4/A
06/14/2022
3:45 PM
C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
Form 4/A
06/14/2022
3:45 PM
C4 Therapeutics (Issuer)
White Lauren (Reporting)
Form 4/A
06/14/2022
3:45 PM
C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
Form 4/A
06/14/2022
3:45 PM
C4 Therapeutics (Issuer)
Crystal Adam (Reporting)
Form 4/A
06/14/2022
3:45 PM
Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
Form 4/A
06/10/2022
7:44 AM
ArrowMark Colorado Holdings LLC (Filed by)
C4 Therapeutics (Subject)
Form SC 13G
06/06/2022
12:31 PM
C4 Therapeutics (Subject)
WASATCH ADVISORS INC (Filed by)
Form SC 13G/A
05/27/2022
3:16 PM
C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2022
3:15 PM
C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2022
3:15 PM
Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2022
3:15 PM
C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2022
7:16 AM
C4 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2022
7:06 AM
C4 Therapeutics (Filer)
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2022
8:18 AM
C4 Therapeutics (Filer)
Form DEFA14A
04/29/2022
8:15 AM
C4 Therapeutics (Filer)
Form DEF 14A
04/12/2022
7:41 PM
C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2021
6:31 PM
C4 Therapeutics (Issuer)
Prokupets Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2021
3:08 PM
C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2021
6:35 PM
C4 Therapeutics (Issuer)
Prokupets Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2021
6:34 PM
C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:49 PM
C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:47 PM
C4 Therapeutics (Issuer)
Prokupets Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:46 PM
C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:44 PM
C4 Therapeutics (Issuer)
Crystal Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2021
3:30 PM
C4 Therapeutics (Issuer)
Salter Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2021
7:00 PM
C4 Therapeutics (Issuer)
Crystal Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
7:23 PM
C4 Therapeutics (Issuer)
Salter Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
7:22 PM
C4 Therapeutics (Issuer)
White Lauren (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
7:21 PM
C4 Therapeutics (Issuer)
White Lauren (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/21/2021
7:08 AM
C4 Therapeutics (Filer)
Form 424B4
06/17/2021
3:16 PM
C4 Therapeutics (Issuer)
DOWNEY BRUCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
3:16 PM
C4 Therapeutics (Issuer)
Prokupets Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
3:15 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
3:15 PM
C4 Therapeutics (Issuer)
Salter Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
3:15 PM
C4 Therapeutics (Issuer)
COHEN ALAIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
3:15 PM
C4 Therapeutics (Issuer)
COHEN MARC A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
11:15 PM
C4 Therapeutics (Filer)
Form EFFECT
06/15/2021
7:31 AM
C4 Therapeutics (Subject)
COBRO VENTURES OPPORTUNITY FUND, L.P. (Filed by)
Form SC 13D/A
06/14/2021
3:17 PM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2021
3:06 PM
C4 Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/07/2021
6:25 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2021
3:28 PM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2021
5:42 PM
C4 Therapeutics (Issuer)
Salter Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2021
3:22 PM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2021
3:37 PM
C4 Therapeutics (Filer)
Form DEFA14A
04/14/2021
3:39 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
3:31 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
3:30 PM
C4 Therapeutics (Issuer)
Crystal Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
3:30 PM
C4 Therapeutics (Issuer)
Salter Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
3:17 PM
C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
3:15 PM
C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2021
3:29 PM
C4 Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2021
3:19 PM
C4 Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2021
3:16 PM
C4 Therapeutics (Issuer)
Wahlberg Laura Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
3:15 PM
C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:48 PM
C4 Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
02/16/2021
2:03 PM
C4 Therapeutics (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G/A
02/04/2021
3:35 PM
C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
3:34 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
4:11 PM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2020
4:00 PM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2020
3:09 PM
C4 Therapeutics (Subject)
COBRO VENTURES OPPORTUNITY FUND, L.P. (Filed by)
Form SC 13D
10/16/2020
3:00 PM
C4 Therapeutics (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G
10/06/2020
8:30 PM
C4 Therapeutics (Issuer)
MCKEE WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
8:28 PM
C4 Therapeutics (Issuer)
COHEN MARC A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
8:27 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
8:27 PM
C4 Therapeutics (Issuer)
DOWNEY BRUCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
8:26 PM
C4 Therapeutics (Issuer)
Salter Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
8:24 PM
C4 Therapeutics (Issuer)
COHEN ALAIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
8:23 PM
C4 Therapeutics (Issuer)
Prokupets Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:46 PM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2020
8:00 PM
C4 Therapeutics (Issuer)
Salter Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
8:00 PM
C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
8:00 PM
C4 Therapeutics (Issuer)
COHEN MARC A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
8:00 PM
C4 Therapeutics (Issuer)
Prokupets Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
8:00 PM
C4 Therapeutics (Issuer)
DOWNEY BRUCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
8:00 PM
Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:CCCC) was last updated on 12/6/2022 by MarketBeat.com Staff